Related Topics
Infectious disease: HPV vaccine appears to be cost-effective way to prevent anal cancer in young males
Jane Kim, assistant professor of health decision science at HSPH, is the author of a study in The Lancet Infectious Diseases on the cost-effectiveness of the human papillomavirus (HPV) vaccine in young men and teen boys. Kim was…
Report calls for schools to adjust lice policies to keep kids in school
HSPH’s Richard Pollack is quoted in a Time magazine article about a report from the American Academy of Pediatrics calling on schools to abandon strict no-nits policies that keep children out of class. Pollack is a research associate…
Global health news: Misconceptions about AIDS
The 18th International AIDS conference takes place July 18-23. In an op-ed for Reuters, AIDS researcher Daniel Halperin, a lecturer in the Department of Global Health and Population, discusses four misconceptions about the global HIV/AIDS epidemic. Link to…
Tuberculosis researcher Sarah Fortune receives clinical scientist development award
July 2, 2010 -- Sarah Fortune, assistant professor of immunology and infectious diseases, has been selected to receive a Clinical Scientist Development Award from the Doris Duke Charitable Foundation. The goal of the CSDA is to encourage the…
AIDS drug combinations given to pregnant women block 99 percent of HIV transmission to breastfed babies
Findings in Botswana Study Suggest Women Taking Antiretroviral Drug Combinations Can Breastfeed Safely For immediate release: Wednesday, June 16, 2010 Boston, MA — An international clinical trial led by researchers at the Harvard School of Public Health (HSPH)…
Infectious disease: lessons learned from H1N1 pandemic
June 14, 2010 -- For the next new infectious threat—or the next phase of the ongoing H1N1 influenza pandemic—public health decision makers need better data about who’s infected and who’s severely sick. And they need it sooner, said…
Blocking malaria parasites
May 2010 -- In a paper published in the May 14 edition of the journal Science, Harvard School of Public Health researchers Manoj Duraisingh and Jeffrey Dvorin succeeded in locking malaria parasites within infected blood cells, potentially containing…
When infection won't quit
[ Spring/Summer 2010 ] TB, AIDS, and malaria are finding new ways to resist treatment Recent headlines paint an insidious trend in infectious disease. In San Francisco, 60 percent of new HIV infections are drug resistant. In Europe and the U.S., a…
New twist on potential malaria drug target acts by trapping parasites in cells
For immediate release: Thursday, May 13, 2010 Boston, MA -- Harvard School of Public Health (HSPH) researchers and colleagues seeking to block invasion of healthy red blood cells by malaria parasites have instead succeeded in locking the parasites…
Many Americans would delay taking recommended antibiotics after anthrax attack, poll finds
Most Americans Would Worry about Serious Illness or Death after Anthrax Attack, But Many Would Delay Taking Recommended Antibiotics For immediate release: Friday, February 19, 2010 Boston, MA – In a national poll aimed at helping with planning…